# OnCo record nct01624090 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct01624090/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct01624090", "NCT01624090" ;
  schema:name "Mithramycin for Lung, Esophagus, and Other Chest Cancers"@en ;
  schema:description "A phase 2 trial of Plicamycin in Lung cancer, Oesophageal cancer, Mesothelioma and Breast cancer, run by National Cancer Institute (NCI), recorded as terminated on the registry."@en ;
  schema:url <https://onco.cc/trials/nct01624090/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01624090> ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/lung-cancer/>, <https://onco.cc/cancers/esophageal/>, <https://onco.cc/cancers/mesothelioma/>, <https://onco.cc/cancers/breast-cancer/> ;
  onco:drugs <https://onco.cc/drugs/plicamycin/> .